设为首页 | 加入收藏 | English
首 页   关于协会  协会动态  会员之声  学术交流  科普宣传  对外交流  癌症康复  期刊杂志  继教科技  科技奖励  协会党建  会员服务  媒体之声
     您当前的位置 : 中国抗癌协会  >  对外交流  >  整合肿瘤学
HIO 医学伦理学专题一览
2025-04-08 17:52

  Holistic Integrative Oncology(HIO,eISSN:2731-4529; CN12-1481/R73)是由中国抗癌协会与Springer Nature出版集团于2021年强强联合打造的一本英文大刊,主编为中国抗癌协会理事长樊代明院士。HIO入选了2022年中国科技期刊卓越行动计划高起点新刊项目,是面向全球开放的自由获取同行评议期刊,设有CACA指南、专家述评、研究综述和原创论著等栏目。医学伦理学专题文章已正式上线,敬请各位读者阅读、引用与分享!

本专题目录

01 Guideline for ethics review of clinical trials

文章类型:Guideline

引用格式:Medical Ethics Society of China Anti-Cancer Association., Hong, M. & Yan, Z. Guideline for ethics review of clinical trials. Holist Integ Oncol 4, 6 (2025). https://doi.org/10.1007/s44178-024-00122-8

图片 

文章链接:https://link.springer.com/article/10.1007/s44178-024-00122-8

02 The development and challenges of Investigator-Initiated Trials (IITs) in China

文章类型:Commentary

引用格式:Hong, M., Yan, Z. The development and challenges of Investigator-Initiated Trials (IITs) in China. Holist Integ Oncol 3, 57 (2024). https://doi.org/10.1007/s44178-024-00123-7

图片 

文章链接:https://link.springer.com/article/10.1007/s44178-024-00123-7

03 The relationship between ethics and innovation: specifically regarding the application and ethical considerations of artificial intelligence in animal models

文章类型:Review

引用格式:Yin, H., Li, Q., Yang, S. et al. The relationship between ethics and innovation: specifically regarding the application and ethical considerations of artificial intelligence in animal models. Holist Integ Oncol 3, 61 (2024). https://doi.org/10.1007/s44178-024-00134-4

图片 

文章链接:https://link.springer.com/article/10.1007/s44178-024-00134-4

04 Practice and reflections on regional mutual recognition of clinical research ethics review——based on survey results from medical and health institutions in Jiangsu Province

文章类型:Original Research

引用格式:Liu, X., Hong, Q., Huang, J. et al. Practice and reflections on regional mutual recognition of clinical research ethics review——based on survey results from medical and health institutions in Jiangsu Province. Holist Integ Oncol 3, 49 (2024). https://doi.org/10.1007/s44178-024-00125-5

图片 

文章链接:https://link.springer.com/article/10.1007/s44178-024-00125-5

05 Current situation and capacity of cancer diagnosis and treatment in county hospitals in China: a multicenter cross-sectional survey

文章类型:Original Research

引用格式:Wang, Y., Sun, T., He, Z. et al. Current situation and capacity of cancer diagnosis and treatment in county hospitals in China: a multicenter cross-sectional survey. Holist Integ Oncol 3, 51 (2024). https://doi.org/10.1007/s44178-024-00124-6

图片 

文章链接:https://link.springer.com/article/10.1007/s44178-024-00105-9

06 Ethical reflections on phase I clinical trials of anticancer drugs: from a Chinese IRB’s empirical perspective

文章类型:Original Research

引用格式:Liu, X., Song, Z., Tang, S. et al. Ethical reflections on phase I clinical trials of anticancer drugs: from a Chinese IRB’s empirical perspective. Holist Integ Oncol 3, 54 (2024). https://doi.org/10.1007/s44178-024-00126-4

图片 

文章链接:https://link.springer.com/article/10.1007/s44178-024-00126-4

07 Perceptions of clinicians and research ethics boards regarding ethical issues in investigator-initiated trials: a multicenter qualitative study in China

文章类型:Original Research

引用格式:Li, J., Yu, H., Wei, X. et al. Perceptions of clinicians and research ethics boards regarding ethical issues in investigator-initiated trials: a multicenter qualitative study in China. Holist Integ Oncol 3, 59 (2024). https://doi.org/10.1007/s44178-024-00132-6

图片 

文章链接:https://link.springer.com/article/10.1007/s44178-024-00132-6

欢迎投稿

HIO诚挚邀请各位专家学者积极投稿!

期刊主页:https://www.springer.com/journal/44178/

投稿链接:https://www.editorialmanager.com/hion/default2.aspx

编辑部邮箱:hio@caca.org.cn

 

版权所有:中国抗癌协会 | 技术支持:北方网 | 联系我们
津ICP备09011441号